The Enterprise Value as of December 2024 (TTM) for Pluri Inc. (PLUR) is 52.05M

According to Pluri Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 52.05M. This represents a change of -3.55% compared to the average of 53.97M of the last 4 quarters.

Pluri Inc. (PLUR) Historical Enterprise Value (quarterly & annually)

How has PLUR Enterprise Value performed in the past?

The mean historical Enterprise Value of Pluri Inc. over the last ten years is 97.47M. The current 52.05M Enterprise Value has changed 5.24% with respect to the historical average. Over the past ten years (40 quarters), PLUR's Enterprise Value was at its highest in in the September 2020 quarter at 263.70M. The Enterprise Value was at its lowest in in the September 2022 quarter at 44.39M.

Pluri Inc. (PLUR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pluri Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pluri Inc. (PLUR) Average Enterprise Value

How has PLUR Enterprise Value performed in the past?

The current Enterprise Value of Pluri Inc. (PLUR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pluri Inc. (PLUR) Enterprise Value vs. Peers

How is PLUR’s Enterprise Value compared to its peers?

Pluri Inc.’s Enterprise Value is greater than BioLineRx Ltd. (44.87M), greater than Purple Biotech Ltd. (4.45M), greater than Aridis Pharmaceuticals, Inc. (4.81M), greater than Enlivex Therapeutics Ltd. (25.04M), less than Transgene SA (76.48M), less than Eupraxia Pharmaceuticals Inc. (151.38M), less than Champions Oncology, Inc. (112.78M), greater than MAIA Biotechnology, Inc. (41.72M), greater than Lumos Pharma, Inc. (24.19M), greater than Evogene Ltd. (7.57M), less than Arcus Biosciences, Inc. (1.31B), less than Fate Therapeutics, Inc. (250.13M), less than Surface Oncology, Inc. (70.21M), less than Compugen Ltd. (138.99M), greater than BiomX Inc. (-3907383.00), less than MediWound Ltd. (199.43M), less than Foghorn Therapeutics Inc. (260.47M), less than Eliem Therapeutics, Inc. (0), greater than Sutro Biopharma, Inc. (9.43M), greater than Dyadic International, Inc. (50.93M),

Build a custom stock screener for Pluri Inc. (PLUR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pluri Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pluri Inc. (PLUR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pluri Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.